Patents by Inventor James Lucot

James Lucot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Emesis treatment
    Patent number: 10646457
    Abstract: A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: May 12, 2020
    Assignee: REPURPOSED THERAPEUTICS, INC
    Inventors: David Helton, James Lucot
  • EMESIS TREATMENT
    Publication number: 20190231714
    Abstract: A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.
    Type: Application
    Filed: February 6, 2019
    Publication date: August 1, 2019
    Inventors: David Helton, James Lucot
  • Emesis treatment
    Patent number: 10206889
    Abstract: A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: February 19, 2019
    Assignee: REPURPOSED THERAPEUTICS, INC.
    Inventors: David Helton, James Lucot
  • EMESIS TREATMENT
    Publication number: 20180161287
    Abstract: A composition for the treatment of emesis comprising 8-hydroxy-2-(dipropylamino)tetralin in which the ratio of the S enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin to the R enantiomer of the 8-hydroxy-2-(dipropylamino)tetralin is between 2:1 and 10:1, and a method of treating or preventing emesis with such a composition.
    Type: Application
    Filed: February 12, 2018
    Publication date: June 14, 2018
    Inventors: David Helton, James Lucot
  • Emesis treatment
    Patent number: 9918949
    Abstract: A method of treating or preventing emesis through the administration of an effective dosage of a 2-(amino)tetralin compound in which one of the S or R enantiomers of the 2-(amino) tetralin compound is present in the composition in excess of the other enantiomer, and compositions comprising such a 2-(amino)tetralin compound in which the ratio of the S and R enantiomers is at least 2:1.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: March 20, 2018
    Assignee: Repurposed Therapeutics, Inc.
    Inventors: David Helton, James Lucot
  • EMESIS TREATMENT
    Publication number: 20150005388
    Abstract: A method of treating or preventing emesis through the administration of an effective dosage of a 2-(amino)tetralin compound in which one of the S or R enantiomers of the 2-(amino) tetralin compound is present in the composition in excess of the other enantiomer, and compositions comprising such a 2-(amino)tetralin compound in which the ratio of the S and R enantiomers is at least 2:1.
    Type: Application
    Filed: July 30, 2014
    Publication date: January 1, 2015
    Inventors: David Helton, James Lucot
  • TREATMENT OF ORGANOPHOSPHATE EXPOSURE WITH TRIPTANS
    Publication number: 20140024641
    Abstract: A method of treating exposure to organophosphate agents and preventing morbidity due to such exposure through the administration of a triptan compound to a subject.
    Type: Application
    Filed: January 7, 2013
    Publication date: January 23, 2014
    Inventors: David Reed HELTON, David Brian FICK, Ernest H. PFADENHAUER, James LUCOT
  • EMESIS TREATMENT
    Publication number: 20120208892
    Abstract: A method of treating or preventing emesis through the administration of an effective dosage of a 2-(amino) tetralin compound in which one of the S or R enantiomers of the 2-(amino) tetralin compound is present in the composition in excess of the other enantiomer, and compositions comprising such a 2-(amino) tetralin compound in which the ratio of the S and R enantiomers is at least 2:1.
    Type: Application
    Filed: October 15, 2010
    Publication date: August 16, 2012
    Applicant: EPIOMED THERAPEUTICS, INC.
    Inventors: David Helton, James Lucot